Literature DB >> 1988891

Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence.

L M Smiley1, T W Burke, E G Silva, M Morris, D M Gershenson, J T Wharton.   

Abstract

About one-half of cervical cancer patients whose tumors recur after radical surgery have negative lymph nodes and clear resection margins. We evaluated 95 patients with squamous cell tumors who underwent radical hysterectomy and pelvic lymphadenectomy between January 1975 and December 1985 and who were thought to be at low risk for recurrence to see whether other clinical or histopathologic factors were predictive of tumor recurrence. Detailed retrospective record review and complete pathology review were accomplished for each case. The 5-year actuarial survival rate was 89%. Nine patients developed recurrent disease (9.5%), of whom eight died. Several clinical features were evaluated as possible prognostic factors: patient age (P = .26), patient race (P = .60), cervical diameter (P = .24), extent of gross cervical involvement (P = .36), and presence of contact bleeding (P = .82). Histopathologic features were examined: depth of invasion (P = .31), number of mitoses (P = .42), character of the tumor-stromal border (P = .15), histologic differentiation (P = .02), lymph-vascular space invasion (P = .56), and width of tumor (P = .23). Depth of invasion did correlate with increasing tumor width (P less than .001). Once node- and margin-positive patients are excluded, differentiation may be the only feature useful in identifying patients at risk for recurrence. Because almost one-half of our patients had poorly differentiated tumors, sole use of this feature as a criterion for adjuvant therapy would have resulted in overtreatment of low-risk patients.

Entities:  

Mesh:

Year:  1991        PMID: 1988891     DOI: 10.1097/00006250-199102000-00022

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  Postoperative radiation therapy for carcinoma of the uterine cervix.

Authors:  Takashi Uno; Koichi Isobe; Seiji Yamamoto; Tetsuya Kawata; Hisao Ito
Journal:  Radiat Med       Date:  2006-02

2.  The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.

Authors:  David Cibula; Lukáš Dostálek; Jiri Jarkovsky; Constantijne H Mom; Aldo Lopez; Henrik Falconer; Anna Fagotti; Ali Ayhan; Sarah H Kim; David Isla Ortiz; Jaroslav Klat; Andreas Obermair; Fabio Landoni; Juliana Rodriguez; Ranjit Manchanda; Jan Kosťun; Ricardo Dos Reis; Mehmet M Meydanli; Diego Odetto; Rene Laky; Ignacio Zapardiel; Vit Weinberger; Klára Benešová; Martina Borčinová; Darwin Pari; Sahar Salehi; Nicolò Bizzarri; Huseyin Akilli; Nadeem R Abu-Rustum; Rosa A Salcedo-Hernández; Veronika Javůrková; Jiří Sláma; Luc R C W van Lonkhuijzen
Journal:  Eur J Cancer       Date:  2021-10-16       Impact factor: 10.002

3.  Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).

Authors:  E Sun Paik; Myong Cheol Lim; Moon-Hong Kim; Yun Hwan Kim; Eun Seop Song; Seok Ju Seong; Dong Hoon Suh; Jong-Min Lee; Chulmin Lee; Chel Hun Choi
Journal:  Cancer Res Treat       Date:  2019-08-05       Impact factor: 4.679

4.  Prognostic significance of poorly differentiated histology and impact of adjuvant chemotherapy in early squamous cell carcinoma of cervix uteri.

Authors:  Hui Luo; Hongxia Yao; Xinxin Xu; Zhen Li; Hongqin Zhao; Haiyan Zhu
Journal:  Cancer Med       Date:  2021-03-18       Impact factor: 4.452

5.  Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer.

Authors:  Huali Wang; Lin Zhu; Weihua Lu; Hui Xu; Yunhai Yu; Yongxia Yang
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754

6.  Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.

Authors:  Koji Matsuo; Rachel S Mandelbaum; Hiroko Machida; Sanjay Purushotham; Brendan H Grubbs; Lynda D Roman; Jason D Wright
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

7.  L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.

Authors:  Marlies Schrevel; Willem E Corver; Margit E Vegter; Natalja T Ter Haar; Enno J Dreef; Jogchum J Beltman; Gemma Kenter; Tjalling Bosse; Cornelis D de Kroon; Ekaterina S Jordanova
Journal:  Oncotarget       Date:  2017-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.